©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 110861
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110861
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110861
Figure 4 Integrated mechanistic map of C15:0 cardioprotection.
Pentadecanoic acid engages lipid, inflammatory, metabolic and mitochondrial pathways that collectively attenuate atherosclerosis and improve cardiometabolic health. AMPK: AMP-activated protein kinase; MCP-1: Monocyte chemoattractant protein-1; PPAR-α/δ: Peroxisome proliferator-activated receptors alpha and delta; GLUT4: Glucose transporter type 4.
- Citation: Mercola J. Pentadecanoic acid (C15:0) and cardiovascular disease: A narrative review. World J Cardiol 2025; 17(12): 110861
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/110861.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.110861